~133 spots leftby Aug 2026

Virtual Care Transition for COPD

(TELE-TOC Trial)

Recruiting in Palo Alto (17 mi)
VG
Overseen byValerie G Press, MD, MPH
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of Chicago
No Placebo Group

Trial Summary

What is the purpose of this trial?

Transitions of Care (TOC) between hospital, ambulatory, and home settings for high-risk, frequently hospitalized adults with chronic diseases, such as chronic obstructive pulmonary disease (COPD) are complex, costly, and vulnerable to safety threats and poor health outcomes. One potential solution to address this gap in care is the Transitional Care Model (TCM), which utilizes a patient-centered approach with in-home interventions; since in-person in-home visits are costly, using innovative telehealth, such as virtual visits via teleconferencing may be just as effective with greater feasibility, scalability, and sustainability, particularly in the post-COVID-19 era as has been seen the rapid expansion of these technologies. With a transdisciplinary team of experts from cognitive science, care transitions/handoffs, human factors engineering, design, implementation science, and health services research, the study team proposes to implement and evaluate via a randomized clinical trial the "TELE-TOC: Telehealth Education: Leveraging Electronic Transitions Of Care for COPD patients," intervention which includes a virtual visit, pharmacy-based, in-home intervention for COPD patients to improve medication use and patient outcomes among a population at high risk for readmission and medication safety events.

Research Team

VG

Valerie G Press, MD, MPH

Principal Investigator

University of Chicago

Eligibility Criteria

This trial is for adults aged 40 or older who have been hospitalized with a COPD exacerbation and are part of the COPD Hospital Readmission Reduction Program. It's designed to help those at high risk for readmission and medication issues.

Inclusion Criteria

I am over 40 and hospitalized for a COPD flare-up.
Enrolled/seen by our COPD Hospital Readmission Reduction Program

Exclusion Criteria

I am younger than 40 years old.
I am currently in the intensive care unit.

Treatment Details

Interventions

  • COPD advanced practice nurse Inpatient Consult (Other)
  • Inpatient Medication Reconciliation (Other)
  • Post-discharge follow-up advanced practice nurse outpatient visit (Other)
  • Post-discharge nurse 48 hour phone follow-up call (Other)
  • Virtual At Home Medication Education Visit(s) (Behavioral Intervention)
  • Virtual at Home Medication Reconciliation Visit(s) (Other)
Trial OverviewThe study tests a telehealth intervention called TELE-TOC, which includes virtual visits and pharmacy-based in-home support after hospital discharge, aiming to improve medication use and health outcomes in COPD patients.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: TELE-TOC plus Usual CareExperimental Treatment6 Interventions
Patients randomized to this arm will receive the TELE-TOC intervention as well as the standard COPD care via the institution's COPD readmission reduction program.
Group II: Usual CareActive Control4 Interventions
Patients randomized to this arm will receive standard COPD care via the institution's COPD readmission reduction program.

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
University of ChicagoChicago, IL
Loading ...

Who Is Running the Clinical Trial?

University of Chicago

Lead Sponsor

Trials
1086
Patients Recruited
844,000+

Society of Hospital Medicine

Collaborator

Trials
6
Patients Recruited
24,200+

COPD Foundation

Collaborator

Trials
18
Patients Recruited
238,000+

Washington University School of Medicine

Collaborator

Trials
2027
Patients Recruited
2,353,000+

Hospital Medicine Reengineering Network (HOMERuN)

Collaborator

Trials
1
Patients Recruited
200+

The American Telemedicine Association

Collaborator

Trials
1
Patients Recruited
200+

Agency for Healthcare Research and Quality (AHRQ)

Collaborator

Trials
415
Patients Recruited
6,777,000+

References